ResearcherErasmus MCActive in the last 2 years
Gwenny Manel Fuhler
Matched on ORCID iD 0000-0001-9221-4855; OpenAlex author ID A5058386574. Sources: OpenAlex.
Their work
- Papers
- 13 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 31
2020: 2 papers · 2021: 1 paper · 2022: 6 papers · 2023: 2 papers · 2024: 2 papers
Papers 13
- Calix[6]arene dismantles extracellular vesicle biogenesis and metalloproteinases that support pancreatic cancer hallmarks. Co-author DOI 10.1016/j.cellsig.2024.111174↗
- Assessment of Glucose and HbA1c Monitoring in a Pancreatic Cancer Surveillance Program for High-Risk Individuals. Co-author DOI 10.14309/ctg.0000000000000777↗
- An 8q24 Gain in Pancreatic Juice Is a Candidate Biomarker for the Detection of Pancreatic Cancer. Co-author DOI 10.3390/ijms24065097↗
- Mutation Analysis of Pancreatic Juice and Plasma for the Detection of Pancreatic Cancer. Co-author DOI 10.3390/ijms241713116↗
- Protein biomarkers in pancreatic juice and serum for identification of pancreatic cancer. Last author DOI 10.1016/j.gie.2022.04.1342↗
- Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individuals. Co-author DOI 10.1016/j.pan.2022.03.021↗
- Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2022.04.010↗
- Systematic review and meta-analysis: Diagnostic performance of DNA alterations in pancreatic juice for the detection of pancreatic cancer. Co-author DOI 10.1016/j.pan.2022.06.260↗
- Three Distinct Stroma Types in Human Pancreatic Cancer Identified by Image Analysis of Fibroblast Subpopulations and Collagen-Letter. Co-author DOI 10.1158/1078-0432.ccr-21-2257↗
- Size and Concentration of Extracellular Vesicles in Pancreatic Juice From Patients With Pancreatic Ductal Adenocarcinoma. Last author DOI 10.14309/ctg.0000000000000465↗
- Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival. Co-author DOI 10.3389/fmed.2021.751110↗
- Upregulated β-catenin signaling does not affect survival of pancreatic cancer cells during dual inhibition of GSK3B and HDAC. Last author DOI 10.1016/j.pan.2019.12.019↗
- Optimization of Pancreatic Juice Collection: A First Step Toward Biomarker Discovery and Early Detection of Pancreatic Cancer. Co-author DOI 10.14309/ajg.0000000000000939↗
Closest collaborators
The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marco J. Bruno · 12 shared papers, 2020–2024 · strength 1.93
- Paper Assessment of Glucose and HbA1c Monitoring in a Pancreatic Cancer Surveillance Program for High-Risk Individuals. DOI 10.14309/ctg.0000000000000777↗
- Paper An 8q24 Gain in Pancreatic Juice Is a Candidate Biomarker for the Detection of Pancreatic Cancer. DOI 10.3390/ijms24065097↗
- Paper Systematic review and meta-analysis: Diagnostic performance of DNA alterations in pancreatic juice for the detection of… DOI 10.1016/j.pan.2022.06.260↗
- Iris J. M. Levink · 11 shared papers, 2020–2024 · strength 1.78
- Paper Assessment of Glucose and HbA1c Monitoring in a Pancreatic Cancer Surveillance Program for High-Risk Individuals. DOI 10.14309/ctg.0000000000000777↗
- Paper An 8q24 Gain in Pancreatic Juice Is a Candidate Biomarker for the Detection of Pancreatic Cancer. DOI 10.3390/ijms24065097↗
- Paper Systematic review and meta-analysis: Diagnostic performance of DNA alterations in pancreatic juice for the detection of… DOI 10.1016/j.pan.2022.06.260↗
- Djuna L. Cahen · 10 shared papers, 2020–2024 · strength 1.64
- Paper Assessment of Glucose and HbA1c Monitoring in a Pancreatic Cancer Surveillance Program for High-Risk Individuals. DOI 10.14309/ctg.0000000000000777↗
- Paper An 8q24 Gain in Pancreatic Juice Is a Candidate Biomarker for the Detection of Pancreatic Cancer. DOI 10.3390/ijms24065097↗
- Paper Systematic review and meta-analysis: Diagnostic performance of DNA alterations in pancreatic juice for the detection of… DOI 10.1016/j.pan.2022.06.260↗
- Maikel Petrus Peppelenbosch · 9 shared papers, 2020–2024 · strength 1.45
- Paper Calix[6]arene dismantles extracellular vesicle biogenesis and metalloproteinases that support pancreatic cancer hallmar… DOI 10.1016/j.cellsig.2024.111174↗
- Paper Systematic review and meta-analysis: Diagnostic performance of DNA alterations in pancreatic juice for the detection of… DOI 10.1016/j.pan.2022.06.260↗
- Paper Mutation Analysis of Pancreatic Juice and Plasma for the Detection of Pancreatic Cancer. DOI 10.3390/ijms241713116↗
- Kateryna Nesteruk · 4 shared papers, 2020–2022 · strength 0.59
- Paper Size and Concentration of Extracellular Vesicles in Pancreatic Juice From Patients With Pancreatic Ductal Adenocarcinom… DOI 10.14309/ctg.0000000000000465↗
- Paper Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarci… DOI 10.1016/j.pan.2022.04.010↗
- Paper Upregulated β-catenin signaling does not affect survival of pancreatic cancer cells during dual inhibition of GSK3B and… DOI 10.1016/j.pan.2019.12.019↗
- Isis J. Visser · 3 shared papers, 2022 · strength 0.52
- Paper Systematic review and meta-analysis: Diagnostic performance of DNA alterations in pancreatic juice for the detection of… DOI 10.1016/j.pan.2022.06.260↗
- Paper Protein biomarkers in pancreatic juice and serum for identification of pancreatic cancer. DOI 10.1016/j.gie.2022.04.1342↗
- Paper Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarci… DOI 10.1016/j.pan.2022.04.010↗
- Brechtje D.M. Koopmann · 3 shared papers, 2022–2024 · strength 0.51
- Paper Assessment of Glucose and HbA1c Monitoring in a Pancreatic Cancer Surveillance Program for High-Risk Individuals. DOI 10.14309/ctg.0000000000000777↗
- Paper Protein biomarkers in pancreatic juice and serum for identification of pancreatic cancer. DOI 10.1016/j.gie.2022.04.1342↗
- Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
- Lydi M.J.W. van Driel · 2 shared papers, 2020–2022 · strength 0.27
- Helon Guimarães Cordeiro · 1 shared paper, 2024 · strength 0.22
- Carmen Veríssima Ferreira‐Halder · 1 shared paper, 2024 · strength 0.22
- Karin Juliane Pelizzaro‐Rocha · 1 shared paper, 2024 · strength 0.22
- Jihane Meziani · 1 shared paper, 2024 · strength 0.22
- Rachid Bouzid · 1 shared paper, 2022 · strength 0.15
- Jerome F. Cros · 1 shared paper, 2022 · strength 0.15
- Michail Doukas · 1 shared paper, 2022 · strength 0.15
- Steven W.M. Olde Damink · 1 shared paper, 2021 · strength 0.13
- Merel R. Aberle · 1 shared paper, 2021 · strength 0.13
- Sander S. Rensen · 1 shared paper, 2021 · strength 0.13
- Lodewijk A.A. Brosens · 1 shared paper, 2021 · strength 0.13
- Manfred Wuhrer · 1 shared paper, 2022 · strength 0.12
- Gerda C. M. Vreeker · 1 shared paper, 2022 · strength 0.12
- Randa G. Hanna-Sawires · 1 shared paper, 2022 · strength 0.12
- Isaura S. Ibrahim · 1 shared paper, 2022 · strength 0.12
- Kasper A. Overbeek · 1 shared paper, 2022 · strength 0.12
- Bert A. Bonsing · 1 shared paper, 2022 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.